Courage Capital Management LLC Novo Cure LTD Transaction History

Courage Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $566,000 - $899,000	-10,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $618,600 - $978,000	-10,000 Reduced 50.0%	10,000 $748,000
Q1 2019 May 14, 2019	SELL	$31.96 - $56.12 $639,200 - $1.12 Million	-20,000 Reduced 50.0%	20,000 $963,000
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $2.3 Million - $4.21 Million	-80,000 Reduced 66.67%	40,000 $1.34 Million
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $4.96 Million - $8.12 Million	-155,000 Reduced 56.36%	120,000 $6.29 Million
Q1 2018 May 14, 2018	BUY	$19.3 - $23.65 $3.38 Million - $4.14 Million	175,000 Added 175.0%	275,000 $6 Million
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $407,500 - $547,500	25,000 Added 33.33%	100,000 $2.02 Million
Q3 2017 Nov 14, 2017	SELL	$18.05 - $21.75 $1.35 Million - $1.63 Million	-75,000 Reduced 50.0%	75,000 $1.49 Million
Q2 2017 Aug 14, 2017	BUY	N/A	150,000	150,000 $2.6 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Courage Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Courage Capital Management LLC with notifications on news.